4791 |
NUCLEAR FACTOR KAPPA B SUBUNIT 2 |
NFKB2 |
CVID10 |
H2TF1 |
LYT-10 |
LYT10 |
NF-kB2 |
p100 |
p49/p100 |
p52 |
164012 |
7795 |
ENSG00000077150 |
OTTHUMG00000018962 |
Q00653 |
NUCLEAR FACTOR NF-KAPPA-B P100/P49 SUBUNITS (DNA-BINDING FACTOR KBF2) (H2TF1) (LYMPHOCYTE TRANSLOCATION CHROMOSOME 10) (ONCOGENE LYT-10) (LYT10) [CONTAINS: NUCLEAR FACTOR NF-KAPPA-B P52 SUBUNIT]. [SOURCE:UNIPROT/SWISSPROT;ACC:Q00653] |
NUCLEAR FACTOR NF-KAPPA-B |
NUCLEAR FACTOR NF-KAPPA-B P100 SUBUNIT |
NFKB2_HUMAN |
NFKB |
T83145 |
Target Class | Transcription factor |
Target Subclass | Transcription factor |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | NF_Rel_dor |
Interpro Name | NF-kappa-B/Rel/dorsal |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Type | Family |
Interpro Acc | IPR000451 |
Uniprot Status | Swiss-Prot |
Gene Biotype | PROTEIN_CODING |
KINASE |
DRUGGABLE GENOME |
CLINICALLY ACTIONABLE |
TRANSCRIPTION FACTOR |
NFKB2 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
NFKB2 | Gene Symbol |
Target Class | Transcription factor |
Target Subclass | Transcription factor |
NUCLEAR FACTOR NF-KAPPA-B P100/P49 SUBUNITS (DNA-BINDING FACTOR KBF2) (H2TF1) (LYMPHOCYTE TRANSLOCATION CHROMOSOME 10) (ONCOGENE LYT-10) (LYT10) [CONTAINS: NUCLEAR FACTOR NF-KAPPA-B P52 SUBUNIT]. [SOURCE:UNIPROT/SWISSPROT;ACC:Q00653] | Description |
ENSG00000077150 | Ensembl Gene Id |
NFKB2 | Display Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
NFKB2_HUMAN | Uniprot Id |
NUCLEAR FACTOR NF-KAPPA-B P100 SUBUNIT | Uniprot Protein Name |
4791 | Entrez Gene Id |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | NF_Rel_dor |
Interpro Name | NF-kappa-B/Rel/dorsal |
DRUGGABLE GENOME |
NFKB | TTD Gene Abbreviation |
T83145 | TTD Target ID |
NFKB | Gene Symbol |
Nuclear factor NF-kappa-B p100 subunit | Gene Name |
Q00653 | UniProt ID |
KINASE, TRANSCRIPTION FACTOR |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |